Evaluating acupuncture for recovery after brain hemorrhage
Efficacy of Acupuncture in Patients With Acute Intracranial Hemorrhage
This study is testing if acupuncture can help people recover better after having a brain bleed.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 20 Years to 85 Years |
| Sex | All |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Locations | 1 site (Keelung) |
| Trial ID | NCT06243237 on ClinicalTrials.gov |
What this trial studies
This study investigates the efficacy of acupuncture in improving functional recovery in patients who have experienced an acute intracranial hemorrhage. Participants will be randomly assigned to receive either traditional acupuncture or a sham acupuncture treatment, with sessions occurring three times a week for at least one week. The study will assess various outcomes, including consciousness, neurological status, and disability, at multiple time points during the treatment period. Biomarkers will also be examined to evaluate the physiological effects of the interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 20 to 85 who have been diagnosed with hemorrhagic stroke and have a Glasgow Coma Scale score between 5 and 13.
Not a fit: Patients with intracranial hemorrhage due to vascular anomalies, tumors, or other neurological conditions, as well as those with terminal illnesses, are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel therapeutic approach to enhance recovery in patients suffering from acute intracranial hemorrhage.
How similar studies have performed: While acupuncture has been explored in various contexts, this specific approach for acute intracranial hemorrhage is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of hemorrhagic stroke by a specialist * Age over 20 years and below 85 years * GCS between 5-13 Exclusion Criteria: * Intracranial hemorrhage resulted from vascular anomalies * Pregnant patients * Intracranial tumor related hemorrhage * Other diseases that can cause neurological deficits, such as old cerebrovascular disease, poliomyelitis, cerebral palsy, spinal cord injury * Organ damage or terminal illness (heart or kidney failure or malignancy)
Where this trial is running
Keelung
- Chang-Gung Memorial Hospital — Keelung, Taiwan (Recruiting)
Study contacts
- Study coordinator: Yan Ru Ko
- Email: b9403213@cgmh.org.tw
- Phone: 886972792003
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.